tenofovir has been researched along with Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buti, M; Calleja, JL; Castillo, P; Esteban, R; García-Retortillo, M; Gómez Rubio, M; Gutiérrez, ML; López, J; Manzano, ML; Martín, L; Morano, LE; Morillas, RM; Prieto, M; Rodríguez, M; Simón, MA; Suárez, E; Yébenes, M; Zozaya, JM | 1 |
1 trial(s) available for tenofovir and Leukemia
| Article | Year |
|---|---|
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Leukemia; Male; Middle Aged; Post-Exposure Prophylaxis; Rituximab; Serologic Tests; Tenofovir | 2017 |